Aptar increases production capacity for preservative free nasal pumps

Aptar Pharma has “significantly increased” the production capacity at its facility in Eigeltingen, Germany for nasal delivery pumps for preservative free formulations, the company says, in order to meet continuously rising demand for preservative free systems. According to Aptar, the company has already sold more than 130 million units of the Advanced Preservative Free (APF) system with tip seal/filter technology and has doubled its production capacity for the units in 2012.

Aptar Pharma CHC Division Director of Business Development Gunter Nadler commented, “APF has been a great product for Aptar Pharma. In particular, our customers in the emerging markets like Latin America or Russia market their nasal spray products equipped with APF with increasing success.”

Share

published on

May 10-May 14RDD 2026, Phoenix, AZ, USA

May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA

May 17-May 20: ATS International Conference 2026, Orlando, FL, USA

June 10SMI.London 2026, London, UK

July 13-July 162026 ISAM Congress, Taipei, Taiwan